• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Moleculin Biotech (MBRX)

Common Shares
Sell: $0.481|Buy: $0.4958|Change: 0.02 (-4.68%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Address

2575 West Bellfort
Suite 333
Houston
TX
USA
77054

Telephone

+1 602 8899700

Website

https://www.moleculin.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Moleculin Biotech Inc Annual General Meeting for 20262026-08-18T10:00:00
Moleculin Biotech Inc Second Quarter Earnings Results for 20262026-08-13T00:00:00
Moleculin Biotech Inc First Quarter Earnings Conference Call for 20262026-05-14T08:30:00
Moleculin Biotech Inc First Quarter Earnings Results for 20262026-05-13T00:00:00
Moleculin Biotech Inc Fourth Quarter Earnings Conference Call for 20252026-03-24T08:30:00
Moleculin Biotech Inc Fourth Quarter Earnings Results for 20252026-03-20T00:00:00
Moleculin Biotech Inc Annual Report for 20252026-03-20T00:00:00
Moleculin Biotech Inc Third Quarter Earnings Conference Call for 20252025-11-11T08:30:00
Moleculin Biotech Inc Third Quarter Earnings Results for 20252025-11-07T00:00:00

Previous key dates

NameKey Date
Moleculin Biotech Inc Annual General Meeting for 20252025-08-18T10:00:00
Moleculin Biotech Inc Second Quarter Earnings Results for 20252025-08-13T00:00:00
Moleculin Biotech Inc First Quarter Earnings Conference Call for 20252025-05-14T08:30:00
Moleculin Biotech Inc First Quarter Earnings Results for 20252025-05-13T00:00:00
Moleculin Biotech Inc Fourth Quarter Earnings Conference Call for 20242025-03-24T08:30:00
Moleculin Biotech Inc Fourth Quarter Earnings Results for 20242025-03-21T00:00:00
Moleculin Biotech Inc Annual Report for 20242025-03-21T00:00:00
37th Annual ROTH Conference2025-03-18T11:00:00
Moleculin Biotech Inc Third Quarter Earnings Conference Call for 20242024-11-11T08:30:00
Moleculin Biotech Inc Third Quarter Earnings Results for 20242024-11-08T00:00:00
Moleculin Biotech Inc Annual General Meeting for 20242024-10-24T10:00:00
2024 Healthcare Virtual Summit, Presented by Maxim Group and hosted by M-Vest2024-10-16T15:00:00
Moleculin Biotech Virtual Acute Myeloid Leukemia KOL Event2024-10-14T11:00:00
3rd Annual ROTH Healthcare Opportunities Conference2024-10-09T13:15:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.